Visceral Pain Treatment Market Is Expanding Rapidly With Takeda Pharmaceutical Company Announcing Results For The Safety And Efficacy Of Subcutaneous Entyvio Indicated For The Treatment Of Moderately To Severely Active Ulcerative Colitis

Visceral Pain Treatment Market


 Visceral pain can be a difficult condition to deal with especially if it affects the abdominal region. Although it is very common, only a small percentage of people who are diagnosed with this condition actually experience severe symptoms. Visceral pain is characterized by an intense pain that originates in the abdomen and radiates from the lower back down the hip area and into the legs. Although some people may only feel mild or moderate discomfort from it, for many this will be a chronic problem that can result in pain permanently. 

Government and pharmaceutical organizations are focused on continuous research and development activities, in order to come up with an innovative approach for visceral pain treatment. Many pharmaceutical companies are involved in collaborative agreements and research to expand their R&D activities. Recently, in February 2020, Novartis collaborated with the Drugs for Neglected Diseases initiative (DNDi) to develop LXE408, a new oral drug for the treatment of visceral leishmaniasis. Hence, such factors can stimulate growth of the visceral pain treatment market.

When it comes to geographical footprint, the U.S. has gained major traction in the visceral pain treatment market. This is typically due to the fact that high awareness regarding the visceral pain treatment market among people and proactive government initiatives to accelerate R&D activities. Similarly, emerging regions such as Asia Pacific are exhibiting promising signs in the field of visceral pain treatment due to the adoption of new treatment methods and improving healthcare infrastructure.

Recently, in October 2020, Takeda Pharmaceutical Company Limited announced results for the safety and efficacy of Subcutaneous Entyvio indicated for the treatment of moderately to severely active ulcerative colitis.   

Nevertheless, there still no specific treatment available for visceral pain. Besides, patent expiration of top drugs is another factor that can inhibit growth of the visceral pain treatment market in the near future. Many pharmaceutical companies have lost their patents for their products in the recent past, while others are likely to lose in the near future.

To start treating Visceral Pain Syndrome, it's important to identify exactly what is causing the abdominal pain.  There are a number of treatments that can be administered to relieve the pain. Some of these methods can be performed at home, while others will require that the person be seen by a trained professional. In general, however, all patients can expect to be given anti-inflammatory medication and possibly given painkillers as well. Abdominal pain is one of the common symptoms of Crohn’s disease. The pain may arise from various mechanisms that include gut digestion and partial blockage. As per the Crohn's & Colitis Foundation of America, around 33,000 new cases of Crohn’s disease are confirmed every year in the U.S. For such severe pains, immediate and effective treatment is required. Hence, such factors can augment growth of the visceral pain treatment market in the near future.  

Comments

Post a Comment

Popular posts from this blog

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Image
  Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome. Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vaccines
Read more

Increasing Geriatric Population Is Driving the Growth of the Sexual Health Market

Image
       Sexual health is an important part of a person’s physical and mental health. According to the World Health Organization (WHO), sexual health requires a respectful and positive approach to sexual relationships and sexuality, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, violence, and discrimination. Sexual health leads to a healthy sex life without any sexually transmitted diseases, and to take preventive measures to avoid sexually transmitted infections. The elderly population (geriatric population) often suffer from one or more sexual disorders, such as premature (early) ejaculation, erectile dysfunctions, dyspareunia, and hypoactive sexual desire disorder, among others. Thus, with the increasing geriatric population worldwide, the prevalence/incidence of sexual disorders is also increasing, driving the growth of the sexual health market . According to WHO, the world's population aged 60 years and older is expected to tota
Read more